P-10, r. 18.3 - Regulation respecting the prescription and interpretation of laboratory analyses by a pharmacist

Full text
Replaced on 25 January 2021
This document has official status.
chapter P-10, r. 18.3
Regulation respecting the prescription and interpretation of laboratory analyses by a pharmacist
Pharmacy Act
(chapter P-10, s. 10, 1st par., subpar. h).
Professional Code
(chapter C-26, s. 95).
Replaced, O.C. 1401-2020, 2020 G.O. 2, 3341A; eff. 2021-01-25; see chapter P-10, r. 3.2.
1. A pharmacist who practises in a centre operated by an institution within the meaning of the Act respecting health services and social services (chapter S-4.2) or within the meaning of the Act respecting health services and social services for Cree Native persons (chapter S-5) may prescribe and interpret laboratory analyses for the purpose of monitoring the drug therapy of a patient admitted to, registered or living in such a centre.
O.C. 603-2013, s. 1.
2. The pharmacist must be a member of the council of physicians, dentists and pharmacists of the institution that operates the centre.
O.C. 603-2013, s. 2.
3. The pharmacist must ensure in advance that no other laboratory analysis to the same effect is available.
O.C. 603-2013, s. 3.
4. The pharmacist must provide the follow-up required.
O.C. 603-2013, s. 4.
5. The pharmacist must enter in the patient’s record the reasons for which the pharmacist prescribes a laboratory analysis and the follow-up given.
O.C. 603-2013, s. 5.
6. (Omitted).
O.C. 603-2013, s. 6; S.Q. 2015, c. 8, s. 205.
REFERENCES
O.C. 603-2013, 2013 G.O. 2, 1510
S.Q. 2015, c. 8, s. 205